Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer
Amr Ahmed WalyEldeen, Salwa Sabet, Haidan M. El-Shorbagy, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110297-110297
Closed Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

Nano-curcumin formulations for targeted therapy of colorectal cancer
Hossein Shahdadi Sardou, Seyedeh Elnaz Nazari, Mohammadreza Abbaspour, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 88, pp. 104943-104943
Closed Access | Times Cited: 8
Synthetic non-toxic anti-biofilm agents as a strategy in combating bacterial resistance
Rasha M. Hassan, Mohamed Samir Abd El-Maksoud, Iman A. Y. Ghannam, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115867-115867
Closed Access | Times Cited: 8
Novel 2‐[thio]acetamide linked quinazoline/1,2,4‐triazole/chalcone hybrids: Design, synthesis, and anticancer activity as EGFR inhibitors and apoptotic inducers
Ahmed S. Abdelkhalek, Hend Kothayer, Moustafa K. Soltan, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access | Times Cited: 2
Allicin affects immunoreactivity of osteosarcoma cells through lncRNA CBR3-AS1
Wen‐Peng Xie, Fengjun Ma, Luming Dou, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31971-e31971
Open Access | Times Cited: 2
Dual functions: A coumarin–chalcone conjugate inhibits cyclic‐di‐GMP and quorum‐sensing signaling to reduce biofilm formation and virulence of pathogens
Yu Zhang, Pramod Bhasme, Dinesh S. Reddy, et al.
mLife (2023) Vol. 2, Iss. 3, pp. 283-294
Open Access | Times Cited: 7
Novel eco-friendly [1,2,4]triazolo[3,4-a]isoquinoline chalcone derivatives efficiency against fungal deterioration of ancient Egyptian mummy cartonnage, Egypt
Neveen S. Geweely, Mona Soliman, Rania A. Ali, et al.
Archives of Microbiology (2023) Vol. 205, Iss. 2
Open Access | Times Cited: 6
Flavonoids as omnipotent candidates for cancer management
Pallavi Chand, Hitesh Kumar, Rupshee Jain, et al.
South African Journal of Botany (2023) Vol. 158, pp. 334-346
Closed Access | Times Cited: 6
Chalcone-based imidazo[2,1- b ]thiazole derivatives: synthesis, crystal structure, potent anticancer activity, and computational studies
Said Dadou, Ahmet Altay, Cemile Baydere, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-16
Closed Access | Times Cited: 6
Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents
Sijongesonke Peter, Blessing A. Aderibigbe
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 7, pp. 644-665
Closed Access | Times Cited: 1
Novel furan chalcone modulates PHD‐2 induction to impart antineoplastic effect in mammary gland carcinoma
Shubham Rastogi, Mohd Nazam Ansari, Abdulaziz S. Saeedan, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 1
Novel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors
Mater H. Mahnashi, Mohammed H. Nahari, Hassan H. Almasoudi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
One-pot three-component synthesis of 6-aryl-3-(arylamino)-5H-thiazolo[3',2':1,2]pyrimido[4,5-b]quinolines utilizing 4-amino-6-oxo-pyrimidin-tethered N-aryl-2-mercaptoacetamides as precursors
Rania Samy Omar, Amr M. Abdelmoniem, Ahmed H. M. Elwahy, et al.
ARKIVOC (2024) Vol. 2024, Iss. 8
Open Access | Times Cited: 1
Synthesis and Antiproliferative Effect of 3,4,5-Trimethoxylated Chalcones on Colorectal and Prostatic Cancer Cells
Cécile Letulle, François-Xavier Toublet, Aline Pinon, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1207-1207
Open Access | Times Cited: 1
Biological Effects and Mechanisms of Dietary Chalcones: Latest Research Progress, Future Research Strategies, and Challenges
Yun Zhang, Shuangjiao Sun, Li Zeng
Food & Function (2024) Vol. 15, Iss. 21, pp. 10582-10599
Closed Access | Times Cited: 1
Novel α-Cyano-Indolyl Chalcones as Anti-Cancer Candidates, Induce G1/S Cell Cycle Arrest and Sequentially Activate Caspases-7, 8 , and 9 in Breast Carcinoma
Alaa A. Kashmiry, Nada S. Ibrahim, Magda F. Mohamed, et al.
Polycyclic aromatic compounds (2024), pp. 1-20
Closed Access | Times Cited: 1
Withanolide derivatives: natural compounds with anticancer potential offer low toxicity to fertility and ovarian follicles in mice
Gaby Judith Quispe Palomino, R.H. Celiz, Francisco Denilson Rodrigues Gomes, et al.
Animal Reproduction (2024) Vol. 21, Iss. 4
Open Access | Times Cited: 1
Discovery of a dual-acting inhibitor of interleukin-1β and STATs for the treatment of inflammatory bowel disease
Haowei Cai, Zhuorong Liu, Ping Sun, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 193-206
Open Access | Times Cited: 4
New bis-heterocyclic structures: Synthesis, characterization and biological activity
Marwan Mohammed Farhan, Mohammed Hadi Ali Al‐Jumaili, Ekhlas Aziz Bakr
Journal of Chemical Research (2023) Vol. 47, Iss. 6
Open Access | Times Cited: 4
Theoretical and molecular mechanistic investigations of novel (3-(furan-2-yl)pyrazol-4-yl) chalcones against lung carcinoma cell line (A549)
Magda F. Mohamed, Nada S. Ibrahim, Amna A. Saddiq, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 4, pp. 719-736
Open Access | Times Cited: 6
Antileishmanial activities of three chalcone derivatives and their association with plasma membrane rigidity as assessed by EPR spectroscopy
E. Borges, Laís Alonso, Murilo Barros Silveira, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136123-136123
Closed Access | Times Cited: 3
Bio-evaluation of the 2-nitrochalcones as potential anti-lung cancer agents, inducers of apoptosis and inhibitors of protein kinase (VEGFR-2)
Malose J. Mphahlele, Garland K. More, Marole M. Maluleka, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 11, pp. 2380-2393
Open Access | Times Cited: 3
Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer
Rama Rao Malla, Satyalakshmi Siragam, Vasudha Dadi, et al.
Critical Reviews in Immunology (2022) Vol. 42, Iss. 6, pp. 27-39
Closed Access | Times Cited: 5
Synthesis of novel acridines, tetrahydrodipyrazolo [3,4-b:4',3'-e]pyridines, tri-substituted methanes (TRSMs) bearing 2-(4-(1-phenyl-1H-pyrazol-3-yl)phenoxy)-N-phenylacetamide unit as novel hybrid molecules
Reham E. Abdelwahab, Ismail A. Abdelhamid, Ahmed H. M. Elwahy, et al.
Synthetic Communications (2023) Vol. 53, Iss. 10, pp. 696-707
Closed Access | Times Cited: 2
Q1VA, a Synthetic Chalcone, Induces Apoptosis and Decreases Invasion on Primary Culture of Human Glioblastoma
Anderson Togni, Tetsade Piermartiri, Luiz Felipe Schmitz de Souza, et al.
Neuroglia (2023) Vol. 4, Iss. 2, pp. 102-118
Open Access | Times Cited: 2
A Novel MDM2-Binding Chalcone Induces Apoptosis of Oral Squamous Cell Carcinoma
Guilherme Freimann Wermelinger, Lucas Rubini-Dias, Anna Carolina Carvalho da Fonseca, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1711-1711
Open Access | Times Cited: 2

Scroll to top